Study on Everolimus and Lutetium (177Lu) Oxodotreotide for Treating Grades 2 and 3 Refractory Meningioma in Patients
- Substances:EverolimusLutetium (177Lu) Oxodotreotide
France- Participants:18–64 years · 65+ years
- Substances:Everolimus
Rare diseases
Investigational molecules
Locations
FranceStudy on Maximizing Methotrexate Therapy for Patients with Active Rheumatoid Arthritis
AustriaStudy on the Effectiveness of Vaginal Micronized Progesterone for Infertility in Patients Undergoing Assisted Conception with Frozen Embryo Transfer (AC-FET)
SpainStudy on Reducing Suicidal Thoughts in Emergency Patients Using Nitrous Oxide and Oxygen Therapy
FranceStudy on Bladder Cancer: Testing Cisplatin and Drug Combination for Patients with Non-Muscle Invasive Bladder Cancer
SpainStudy on Diacerein 1% Ointment for Treating Generalized Epidermolysis Bullosa Simplex in Patients Aged 6 Months and Older
AustriaStudy of NVL-520 for Patients with Advanced ROS1-Positive Lung Cancer and Other Solid Tumors
BelgiumStudy of PC14586 for Patients with Advanced Solid Tumors with a Specific TP53 Mutation
FranceStudy of LTX-315 and Pembrolizumab for Patients with Resectable Stage III-IV Melanoma
NorwayStudy on Melphalan, Ipilimumab, and Nivolumab for Patients with Uveal Melanoma Liver Metastases
NorwayStudy on Detecting Hidden Invasive Breast Cancer in Patients with Ductal Carcinoma In Situ Using [68Ga]FAPI-46 and Gadobutrol
GermanyStudy Comparing Pirtobrutinib and Ibrutinib for Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
AustriaTell us about your condition – we search every trial in Europe and connect you with the right site.